Visados de inspección: ¿garantía del uso adecuado de los medicamentos o medida de control del gasto?

Gutiérrez-Nicuesa, L; Magaz-Marqués, S; Badia-Llach, X.
Aten. prim. (Barc., Ed. impr.) ; 37(5): 278-286, mar. 2006. ilus, tab
Artigo em Es | IBECS (Espanha) | ID: ibc-045847

Documentos relacionados

  1. Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System.
  2. Association of Initial Provider Type on Opioid Fills for Individuals With Neck Pain.
  3. Inercia clínica en el tratamiento con insulina en el primer nivel de atención.
  4. Evaluation of Factors Associated With Successful Matriculation to Colon and Rectal Surgery Fellowship.
  5. Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people.
  6. Patterns and determinants of prescribed drug use among pregnant women in Adigrat general hospital, northern Ethiopia: a cross-sectional study.
  7. Estimating the impact of self-management education, influenza vaccines, nebulizers, and spacers on health utilization and expenditures for Medicaid-enrolled children with asthma.
  8. Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave.
  9. The impacts of national centralized drug procurement policy on drug utilization of medical institutions: an empirical study in a county-level hospital in China.
  10. Age-related decline in antibiotic prescribing for uncomplicated respiratory tract infections in primary care in England following the introduction of a national financial incentive (the Quality Premium) for health commissioners to reduce use of antibiotics in the community: an interrupted time series analysis.